Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Its structure allows for easy handling in various in vitro and in vivo research protocols
The pharmacological options were often disappointing: Sulfonylureas and insulin lower blood sugar but caused weight gain, exacerbating the underlying problem
In December 2023, it became the first prescription medicine to be approved for moderate OSA in adults with obesity
In rats, therefore, the appetite suppressing effects of these drugs do not show a sex bias
10.1136/bmj.k4365 147 UssherJ
US$ 20.35
US$ 26.13
US$ 29.53
US$ 27.77
US$ 28.63
US$ 24.22
US$ 28.64
US$ 26.52
